What we don't need to prove but need to do in multidisciplinary treatment and care in Huntington's disease: a position paper.
Care
Case manager
Guidelines
Huntington’s disease
Interdisciplinary team
Managed care network
Multidisciplinary treatment
Position paper
Journal
Orphanet journal of rare diseases
ISSN: 1750-1172
Titre abrégé: Orphanet J Rare Dis
Pays: England
ID NLM: 101266602
Informations de publication
Date de publication:
30 01 2023
30 01 2023
Historique:
received:
25
11
2022
accepted:
15
01
2023
entrez:
31
1
2023
pubmed:
1
2
2023
medline:
2
2
2023
Statut:
epublish
Résumé
Huntington's disease is a complex neurodegenerative hereditary disease with symptoms in all domains of a person's functioning. It begins after a healthy start in life and leads through the relentless progression over many years to complete care dependency and finally death. To date, the disease is incurable. The long progressive complex nature of the disease demands multiple disciplines for treatment and care of patient and family. These health care providers need inter- and multidisciplinary collaboration to persevere and be efficacious in this devastating disease trajectory. The position paper outlines current knowledge and experience alongside the experience and consensus of a recognised group of HD multidisciplinary experts. Additionally the patient's voice is clear and calls for health care providers with a holistic view on patient and family. Building long-term trust is a cornerstone of the network around the patient. This paper describes a managed care network comprising all the needed professionals and services. In the health care system, the role of a central coordinator or case manager is of key importance but lacks an appropriate guideline. Other disciplines currently without guidelines are general practitioners, nurses, psychologists, and social workers. Guidelines for neurologists, psychiatrists, geneticists, occupational therapists, speech and language therapists, physiotherapists, dieticians, and dentists are being discussed. Apart from all these profession-specific guidelines, distinctive inter- and multidisciplinary collaboration requirements must be met. The complex nature of Huntington's disease demands multidisciplinary treatment and care endorsed by international regulations and the lay association. Available guidelines as reviewed in this paper should be used, made available by a central body, and updated every 3-5 years. Time needs to be invested in developing missing guidelines but the lack of this 'proof' should not prevent the 'doing' of good care.
Sections du résumé
BACKGROUND
Huntington's disease is a complex neurodegenerative hereditary disease with symptoms in all domains of a person's functioning. It begins after a healthy start in life and leads through the relentless progression over many years to complete care dependency and finally death. To date, the disease is incurable. The long progressive complex nature of the disease demands multiple disciplines for treatment and care of patient and family. These health care providers need inter- and multidisciplinary collaboration to persevere and be efficacious in this devastating disease trajectory.
DISCUSSION
The position paper outlines current knowledge and experience alongside the experience and consensus of a recognised group of HD multidisciplinary experts. Additionally the patient's voice is clear and calls for health care providers with a holistic view on patient and family. Building long-term trust is a cornerstone of the network around the patient. This paper describes a managed care network comprising all the needed professionals and services. In the health care system, the role of a central coordinator or case manager is of key importance but lacks an appropriate guideline. Other disciplines currently without guidelines are general practitioners, nurses, psychologists, and social workers. Guidelines for neurologists, psychiatrists, geneticists, occupational therapists, speech and language therapists, physiotherapists, dieticians, and dentists are being discussed. Apart from all these profession-specific guidelines, distinctive inter- and multidisciplinary collaboration requirements must be met.
CONCLUSIONS AND RECOMMENDATIONS
The complex nature of Huntington's disease demands multidisciplinary treatment and care endorsed by international regulations and the lay association. Available guidelines as reviewed in this paper should be used, made available by a central body, and updated every 3-5 years. Time needs to be invested in developing missing guidelines but the lack of this 'proof' should not prevent the 'doing' of good care.
Identifiants
pubmed: 36717864
doi: 10.1186/s13023-023-02622-8
pii: 10.1186/s13023-023-02622-8
pmc: PMC9887752
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
19Informations de copyright
© 2023. The Author(s).
Références
Front Neurol. 2019 Jul 03;10:710
pubmed: 31333565
Clin Genet. 2013 Mar;83(3):221-31
pubmed: 22642570
J Nerv Ment Dis. 1974 Jan;158(1):61-9
pubmed: 4272128
Orphanet J Rare Dis. 2010 Dec 20;5:40
pubmed: 21171977
Arch Clin Neuropsychol. 2017 Nov 1;32(7):876-887
pubmed: 28961886
Lancet Psychiatry. 2016 Nov;3(11):1079-1086
pubmed: 27663851
BMC Med Inform Decis Mak. 2013;13 Suppl 3:S6
pubmed: 24565268
J Neurol Neurosurg Psychiatry. 2014 Dec;85(12):1411-8
pubmed: 24828898
J Neurol Neurosurg Psychiatry. 2001 Sep;71(3):310-4
pubmed: 11511702
Curr Neurol Neurosci Rep. 2012 Aug;12(4):359-66
pubmed: 22544535
HEC Forum. 1996 Mar;8(2):109-25
pubmed: 10158146
J Huntingtons Dis. 2018;7(3):355-366
pubmed: 30040737
Mov Disord. 2014 Sep 15;29(11):1404-13
pubmed: 25164707
Pract Neurol. 2022 Feb;22(1):32-41
pubmed: 34413240
Brain Behav. 2015 Feb;5(2):e00312
pubmed: 25642394
J Neuropsychiatry Clin Neurosci. 2012 Winter;24(1):53-60
pubmed: 22450614
Front Psychiatry. 2019 Apr 12;10:221
pubmed: 31031659
NeuroRehabilitation. 2018;43(4):443-471
pubmed: 30412509
Brain Res Bull. 2007 Apr 30;72(2-3):175-8
pubmed: 17352943
Neurology. 2020 Feb 4;94(5):217-228
pubmed: 31907286
Pilot Feasibility Stud. 2020 Jun 19;6:88
pubmed: 32577299
Acta Inform Med. 2008;16(4):219-25
pubmed: 24109156
Curr Neurol Neurosci Rep. 2019 Nov 13;19(11):83
pubmed: 31720865
Curr Psychiatry Rep. 2017 Feb;19(2):9
pubmed: 28168595
Mov Disord. 2018 Feb;33(2):187-195
pubmed: 29278291
Arch Psychiatr Nurs. 2021 Jun;35(3):284-289
pubmed: 33966794
J Neurol Sci. 2020 Sep 15;416:117022
pubmed: 32688143
Oral Dis. 2023 Jan;29(1):62-74
pubmed: 34773332
J Geriatr Psychiatry Neurol. 1998 Summer;11(2):61-70
pubmed: 9877527
Orphanet J Rare Dis. 2015 Sep 28;10:124
pubmed: 26411462
Cell. 1993 Mar 26;72(6):971-83
pubmed: 8458085
Brain Sci. 2017 Jun 16;7(6):
pubmed: 28621715
Neurosci Lett. 2007 Apr 18;416(3):272-4
pubmed: 17321683
J Huntingtons Dis. 2020;9(3):231-243
pubmed: 32894248
Pract Neurol. 2015 Feb;15(1):80-4
pubmed: 25169240
Scand J Caring Sci. 2015 Dec;29(4):803-9
pubmed: 25920040
Handb Clin Neurol. 2017;144:69-91
pubmed: 28947127